|
RPLP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.266560E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.008800E-01 |
| Normal-vs-Stage2 |
4.249400E-01 |
| Normal-vs-Stage3 |
6.867700E-02 |
| Normal-vs-Stage4 |
1.517780E-01 |
| Stage1-vs-Stage2 |
8.930000E-01 |
| Stage1-vs-Stage3 |
2.103800E-01 |
| Stage1-vs-Stage4 |
5.684400E-01 |
| Stage2-vs-Stage3 |
6.230600E-01 |
| Stage2-vs-Stage4 |
8.470400E-01 |
| Stage3-vs-Stage4 |
6.207800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.665700E-02 |
| Normal-vs-AfricanAmerican |
3.205400E-01 |
| Normal-vs-Asian |
6.616000E-01 |
| Caucasian-vs-AfricanAmerican |
6.567200E-01 |
| Caucasian-vs-Asian |
2.250200E-01 |
| AfricanAmerican-vs-Asian |
5.755000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.788200E-02 |
| Normal-vs-Female |
2.148400E-01 |
| Male-vs-Female |
2.549200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.332650E-01 |
| Normal-vs-Age(41-60Yrs) |
1.280420E-01 |
| Normal-vs-Age(61-80Yrs) |
3.507600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.690200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.597200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.447400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.906400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.569400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.978200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.752200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.794000E-01 |
| Classical-VS-Follicular |
4.586400E-01 |
| Classical-VS-Other |
4.261700E-02 |
| Classical-VS-Normal |
1.327200E-01 |
| Tall-VS-Follicular |
1.430410E-01 |
| Tall-VS-Other |
7.108400E-01 |
| Tall-VS-Normal |
7.248100E-02 |
| Follicular-VS-Other |
2.332100E-02 |
| Follicular-VS-Normal |
5.639200E-01 |
| Other-VS-Normal |
9.558200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.212790E-01 |
| Normal-vs-N1 |
6.835900E-02 |
| N0-vs-N1 |
4.702000E-01 |
|
|
